IDXG
Interpace Biosciences Inc
Price:
0.8
USD
Volume:
3,470
United States | Health Care Providers & Services
IDXG Gross Margin
As of 2025-07-13, the Gross Margin of Interpace Biosciences Inc (IDXG) is 63.8%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
IDXG Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 63.8% |
| 2023-12-31 | 62.7% |
| 2022-12-31 | 57.2% |
| 2021-12-31 | 56.8% |
| 2020-12-31 | 33% |
| 2019-12-31 | 34.3% |
| 2018-12-31 | 53.4% |
| 2017-12-31 | 53.5% |
| 2016-12-31 | 49.6% |
| 2015-12-31 | 26.6% |
IDXG Gross Margin - Peers Comparison